| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1097/00001622-199701000-00013 |
| P698 | PubMed publication ID | 9090498 |
| P50 | author | Wafik El-Deiry | Q4118647 |
| P2093 | author name string | el-Deiry WS | |
| P433 | issue | 1 | |
| P304 | page(s) | 79-87 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Current Opinion in Oncology | Q1909046 |
| P1476 | title | Role of oncogenes in resistance and killing by cancer therapeutic agents | |
| P478 | volume | 9 |
| Q21133027 | 13-methyltetradecanoic acid exhibits anti-tumor activity on T-cell lymphomas in vitro and in vivo by down-regulating p-AKT and activating caspase-3 |
| Q35549014 | African flora has the potential to fight multidrug resistance of cancer |
| Q42006571 | African medicinal plants and their derivatives: Current efforts towards potential anti-cancer drugs |
| Q36261259 | Anticancer activity of NOB1-targeted shRNA combination with TRAIL in epithelial ovarian cancer cells |
| Q39102933 | Apicidin-resistant HA22T hepatocellular carcinoma cells massively promote pro-survival capability via IGF-IR/PI3K/Akt signaling pathway activation |
| Q35091131 | Apoptosis in hematological disorders. |
| Q40976644 | Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene |
| Q34517743 | Apoptosis-related mRNA expression profiles of ovarian cancer cell lines following cisplatin treatment. |
| Q34520432 | Apoptosis: a link between cancer genetics and chemotherapy |
| Q40771883 | BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance |
| Q35022527 | BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability |
| Q34153467 | Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences |
| Q73295685 | Clinical importance of correlations between p53 immunoreactivity and clinicopathological parameters in lung carcinoma |
| Q37640084 | Cytochrome P450 and P-Glycoprotein-Mediated Interactions Involving African Herbs Indicated for Common Noncommunicable Diseases. |
| Q38974581 | Cytotoxic flavonoids and isoflavonoids from Erythrina sigmoidea towards multi-factorial drug resistant cancer cells. |
| Q38859679 | Cytotoxicity of anthraquinones from the roots of Pentas schimperi towards multi-factorial drug-resistant cancer cells |
| Q36093027 | Cytotoxicity of methanol extracts of 10 Cameroonian medicinal plants towards multi-factorial drug-resistant cancer cell lines |
| Q34542379 | Cytotoxicity of methanol extracts of Annona muricata, Passiflora edulis and nine other Cameroonian medicinal plants towards multi-factorial drug-resistant cancer cell lines |
| Q35765152 | Cytotoxicity of selected Cameroonian medicinal plants and Nauclea pobeguinii towards multi-factorial drug-resistant cancer cells |
| Q34139596 | Death receptor signals to mitochondria |
| Q28478307 | Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells |
| Q57363958 | Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells |
| Q34255576 | Disruption of microtubules sensitizes the DNA damage-induced apoptosis through inhibiting nuclear factor κB (NF-κB) DNA-binding activity |
| Q73594080 | Diverse effects of 9-hydroxyellipticine on the chemosensitivity of human pancreatic cancer cells harboring p53 mutations |
| Q33758382 | Evolution of acquired resistance to anti-cancer therapy |
| Q40676163 | Fusion oncogenic tyrosine kinases alter DNA damage and repair after genotoxic treatment: role in drug resistance? |
| Q34281241 | Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis |
| Q40734383 | Gene expression profiling by cDNA array in human hepatoma cell line in response to cisplatin treatment |
| Q73540284 | Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors |
| Q33991690 | Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling |
| Q36698389 | HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer |
| Q28611377 | Homologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance |
| Q38945474 | Identification of cellular and molecular factors determining the response of cancer cells to six ergot alkaloids. |
| Q40290230 | In vitro studies of DNA damage and its repair in cells from NHL patients with different p53 mutant protein status, resistant (p53(+)) and sensitive (p53(-)) to cancer chemotherapy |
| Q30306196 | Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis |
| Q54334207 | Keeping those telomeres short! an innovative intratumoral long-term drug delivery system. |
| Q36469814 | MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer |
| Q35791530 | MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model |
| Q80160635 | Methods and goals for the use of in vitro and in vivo chemosensitivity testing |
| Q40912214 | Mitochondrial DNA determines the cellular response to cancer therapeutic agents |
| Q34224839 | Molecular markers predictive of response to chemotherapy in gastrointestinal tumors. |
| Q74576168 | Multidrug resistance gene (MDR-1) expression as a useful prognostic factor in patients with human hepatocellular carcinoma after surgical resection |
| Q34085592 | Multidrug resistance: a role for cholesterol efflux pathways? |
| Q78151657 | Mutations in the Saccharomyces cerevisiae gene SAC1 cause multiple drug sensitivity |
| Q38059212 | Non-invasive imaging of PI3K/Akt/mTOR signalling in cancer. |
| Q34665985 | Oncogenic tyrosine kinases and the DNA-damage response |
| Q35550932 | Overcoming Antiapoptotic Responses to Promote Chemosensitivity in Metastatic Colorectal Cancer to the Liver |
| Q38777193 | Pharmacogenomics of Scopoletin in Tumor Cells. |
| Q40668185 | Radiation therapy depletes extrachromosomally amplified drug resistance genes and oncogenes from tumor cells via micronuclear capture of episomes and double minute chromosomes |
| Q34166893 | Role of Bcl-2 and its post-transcriptional modification in response to antitumor therapy. |
| Q38919533 | Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo |
| Q48445482 | Survivin inhibitor YM155 induces mitochondrial dysfunction, autophagy, DNA damage and apoptosis in Bcl-xL silenced glioma cell lines. |
| Q38269745 | Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals |
| Q44519243 | The effect of adenovirus-IkappaBalpha transduction on the chemosensitivity of lung cancer cell line with resistance to cis-diamminedichloroplatinum(II)(cisplatin) and doxorubicin(adriamycin). |
| Q34267620 | The receptor tyrosine kinases: role in cancer progression. |
| Q73816253 | The staurosporine analog, Ro-31-8220, induces apoptosis independently of its ability to inhibit protein kinase C |
| Q37211956 | USP2a alters chemotherapeutic response by modulating redox. |
| Q34365159 | Upregulation of caveolin in multidrug resistant cancer cells: functional implications |
Search more.